CLINICAL_TRIALS
trial_result
· 2020-09-22
Clinical Trial Update: IMT for Primary Clostridium Difficile Infection [Phase 2, Phase 3]
Summary
A clinical trials update for IMT in primary Clostridium difficile infection covering Phase 2 and Phase 3, with the study terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oslo University Hospital | Conditions: Clostridium Difficile Infection | Phase 2, Phase 3 | Status: TERMINATED